SEC Form 4 research
| Issuer | Entero Therapeutics, Inc. |
|---|---|
| Tickers | FWBI, ENTO, AZRX, GRDX |
| Reporting owners | 26 |
| Officers and directors | 4 |
| Last public filing | 2026-10-09 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-09 | 2026-09-30 | Sawyer Jason David | A | 250,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.